Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2011 June;59(3) > Minerva Cardioangiologica 2011 June;59(3):235-8

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Minerva Cardioangiologica 2011 June;59(3):235-8

Copyright © 2011 EDIZIONI MINERVA MEDICA

language: English

Drug eluting stents for saphenous vein graft interventions

Banerjee S. 1, 2, Master R. 2, Iqbal A. 2, Brilakis E. S. 1. 2

1 VA North Texas Healthcare System, Washington, DC, USA 2 University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA


PDF


Drug eluting stents (DES) have improved percutaneous coronary intervention (PCI) outcomes for most coronary lesion subsets and have gained widespread acceptance. This practice is supported by large-scale clinical trials. Evidence for DES use for treatment of saphenous vein graft (SVG) lesions is less well defined and often conflicting. Most SVG interventions are performed in the setting of an acute coronary syndrome (ACS), in large caliber vascular conduits with soft and friable plaque with inflammatory debris, without a fibrous cap. In this review, we provide an up to date assessment of the published evidence on DES use in PCI of SVG lesions.

top of page